The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase II study assessing the benefit of cisplatin re-introduction (stop and go strategy) in patients with advanced non-squamous non-small cell lung cancer (NSCLC): The IFCT-1102 BUCiL study (a Better Use of Cisplatin in Lung cancer).
 
Fabrice Barlesi
No Relationships to Disclose
 
Judith Raimbourg
No Relationships to Disclose
 
Pascal Do
No Relationships to Disclose
 
Patrick Dumont
No Relationships to Disclose
 
Jacques Cadranel
Honoraria - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Lilly; Novartis; Pfizer; Roche
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Lilly; Novartis; Pfizer; Roche
 
Didier Debieuvre
No Relationships to Disclose
 
Werner Hilgers
Honoraria - AstraZeneca; Janssen-Cilag; Roche
Consulting or Advisory Role - Sanofi
Travel, Accommodations, Expenses - Chugai Pharma
 
Pierre Jean Souquet
Honoraria - AstraZeneca; Bristol-Myers Squibb; Roche
Consulting or Advisory Role - Lilly/ImClone; PFIZER; Roche/Genentech
Speakers' Bureau - Amgen; AstraZeneca; boehringer ingelheim; Lilly/ImClone; pfizer; Roche/Genentech
Research Funding - AstraZeneca; Boehringer Ingelheim; Clovis Oncology; GlaxoSmithKline; LILLY (Inst); Novartis; Roche/Genentech (Inst)
Travel, Accommodations, Expenses - LILLY; PFIZER
 
Olivier Molinier
No Relationships to Disclose
 
Elisabeth A. Quoix
Consulting or Advisory Role - Abbvie; Boehringer Ingelheim; Roche/Genentech
Travel, Accommodations, Expenses - MSD Oncology; Pfizer; Roche
 
Alexandra Langlais
No Relationships to Disclose
 
Marie Paule Lebitasy
No Relationships to Disclose
 
Franck Morin
No Relationships to Disclose
 
Gerard Zalcman
Honoraria - Lilly; Pfizer; Roche
Consulting or Advisory Role - Boehringer Ingelheim (Inst); Bristol-Myers Squibb; Bristol-Myers Squibb; Lilly (Inst); Pfizer (Inst); Roche (Inst)
Research Funding - AstraZeneca (Inst); Pfizer (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Lilly; Pfizer; Pfizer; Roche
 
Jaafar Bennouna
Honoraria - Boehringer Ingelheim; Novartis; Pierre Fabre; roche
Consulting or Advisory Role - Boehringer Ingelheim; Novartis; Pierre Fabre; Roche